0001104659-18-041872.txt : 20180622
0001104659-18-041872.hdr.sgml : 20180622
20180622213136
ACCESSION NUMBER: 0001104659-18-041872
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180621
FILED AS OF DATE: 20180622
DATE AS OF CHANGE: 20180622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZUERBLIS KENNETH J
CENTRAL INDEX KEY: 0001007923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 18915855
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE RD
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2018-06-21
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001007923
ZUERBLIS KENNETH J
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
1
0
0
0
Common Stock
2018-06-21
4
A
0
13158
0
A
45121
D
The restricted shares will vest according to the following schedule: 4,386 shares on 6/21/2019, 4,386 shares on 6/21/2020 and 4,386 shares on 6/21/2021.
Of the 45,121 shares, 23,157 shares are restricted stock.
/s/ Kenneth Hoberman, Attorney-in-Fact
2018-06-22